Articles related to Biotechnology
Program lead stresses immediate and persistent benefits - program's 4th year option to be reviewed.
[Updated] Four Black-led companies are already in the portfolio of $55MM fund, with a half-dozen more deals likely in the next 12 months.
White House scitech advisors suggest AI, biotech, comms, quantum infoscience, advanced manufacturing initiatives.
[updated] Fighting colorectal cancer, CEO eyes growing Knoxville biotech scene and Euro and U.S. markets
As bill-filing deadlines loom, bills that shape TN economy, startups, entrepreneurial momentum are in prospect.
The word is just getting out about new entrant in Tennessee biopharm ecosystem.
Another regional accelerator goes-it alone, capital formation numbers, and more.
VTC For the 14th year, investors, entrepreneurs, strategic corporates meld at FedEx Institute.
Developers studying HudsonAlpha and other innovation centers.
[Updated] Team says rapid Angel-investor enlistment is one reason this is a 'W' for region's LifeSciences
Breast cancer target, regulatory progress and further capital raise action likely.
[updated] Financing spurs Type 2 diabetes, non-alcoholic fatty liver programs
Drug-discovery, partnerships and commercialization among conference highlights
[EMIDS update Dec. 5, 2013] Maybe it's time to focus on something more than our reported shortage of coders
VTC TNInvestco's network effect is just one source of encouragement, but there remain issues to ponder
Helping doc's pick the right genetic tests is the mission of this Web-based marketplace
Entrepreneur says she's found more than a good lease in Nashville
Gleanings from Tennessee media touching upon life-sciences issues and opportunities
In Memphis, this Innova-backed venture's fate is still years away, but rewards may be huge
With relatively little fanfare, one TNInvestco fund is rebranding and entrepreneurial activity heats-up statewide.
Scholar and entrepreneur will co-found molecular diagnostics startup in Nashville
Two pharmas are already aboard and other allies for accelerating drug development may be in-the-offing
Law firm broadens its already sizeable footprint, plants flag in dealing with early-stage ventures
Sir John Templeton's grand-niece is taking on neuro-economics and gender issues, with backing from a hedge-fund pioneer
Nashville and Tennessee are quickly becoming year-round innovation venues, as this sampling of events makes clear
Pfizer, Kleiner Perkins, et al, have given another vote of confidence to this Bay Area-based venture aiming at MLS, Cancer and other diseases
Education Networks..StudioNow..Biotechies...Scripps Interactive..Aegis Health... VU's science reports, and more..
The boom in genetic research and some apparently market-ready technology suggest an interesting vehicle for early-stage investment
Nanotechnology innovation promises better drug delivery for treatment of numerous diseases
Technology-enterprise advocate believes life-sciences sector cannot advance without stronger leadership
[updated] Though their faith in the future may vary, retained executive-search professionals are investing energy in Bio and related fields.
The yet-to-be-operational TNInvestco capital-formation program seems to have kindled fresh interest in key sectors
[UPDATED Aug. 11, 6:53 a.m.] Cumberland Pharmaceuticals' IPO filing became effective yesterday and trades today as CPIX, 27 months after the shelf registration and 20 subsequent amendments
New leader says NTC will undertake a strategic review of its mission and programs, later this summer
By enlisting a squad of scientists based here, this California firm has created a pathway of its own into Nashville's fledgling biotechnology community
A supposed transformation of education, plus sustained support from key moneymen seem to have given ALS staying-power
The Pitt Hyde-founded life-sciences investor will soon be on the prowl again, in a target-rich marketplace of down-valued companies
Life-sciences company says it's still focused on move, but sales lag and economic conditions creating headwind
At deal-making summit, investment bankers and others say focus on regulatory pressure for cost-reductions, rather than on next President
While critics sound off and Biotech targets General Assembly, an economy-shaping executive keeps pushing education and innovations
Farris Warfield Kanaday gave a 27-year-old lawyer some running room in the late Nineties, and he used it to launch NTC
Now, after selling its first FDA-approved product to a close ally, BioMimetic is flush with cash and experience -- and committed to developing biotechnologies in Middle Tennessee.
For nearly five years, News of Nashville Technology has served the expanding local science and technology community. Publication resumes in April.